Our science is patient-centric by design. We incorporate Patient and Public Involvement (PPI) to ensure that our outcomes and communication align with the needs and expectations of those affected.

(Image credit for the visual on the bottom left: Copyright © 2006 Volker Steger/Science Photo Library)

We focus on the Tumor Microenvironment (TME) at metastatic sites (bone, liver, brain)—not just the primary tumor.

💥 We investigate macrophages, immune cells that often become corrupted, acting as cancer's allies. By successfully "re-educating" these cells, we aim to create new therapeutic pathways.

Metastatic disease affects 20-30% of early breast cancer patients. This is the frontier where we need to focus.🎯

Mac4Me’s goal is to help transform metastatic breast cancer from a typically terminal condition into a chronic or potentially curable one.

#MetastaticBreastCancerAwarenessDay

We, at the Mac4Me Horizon Europe MSCA (Marie Skłodowska-Curie Actions) Doctoral Network, embody this spirit by bringing together researchers, patients, and other stakeholders to address the challenges of metastatic neuroblastoma, prostate, and breast cancer. Learn more about our work: www.mac4me.eu

Today, September 24th, is #WorldCancerResearchDay. It is a yearly momentum to raise
awareness and commitment for cancer research. This day also serves as a reminder that
progress depends on collaboration.

Hugely excited to meet the @mac4me.bsky.social team in Rotterdam for our kick-off meeting. Here with @peptimatrix.bsky.social and a whole interdisciplinary team ’opening new doors in cancer immunotherapy’ www.mac4me.eu

The @mac4me.bsky.social project officially kicked off in Rotterdam on 25-26 June! It was great to connect with partners in person and meet our DC, Elena Montero Bragado.

🔗 Read the Full story: www.peptimatrix.com/post/mac4me-...

#Mac4Me #HorizonEurope #CancerResearch #3DCellCulture #MSCA

🌍 Led by 14 core partners and supported by 11 associated partners, this project brings together experts from basic science, biomedical engineering, social sciences, computational biology, and other disciplines.
To learn more about our mission, visit our website: 🌐🔗 mac4me.eu

The atmosphere throughout the meeting was positive and productive! ✨This initial in-person encounter created significant consortium cohesion for many participants. This lays the groundwork for scientific and technical collaboration over the next four years. 🤝

A significant part of the training focused on Patient and Public Involvement (PPI)! 🧑‍🤝‍🧑 Patient advocates from Dublin (PVCR) and the US (@graspcancer.bsky.social) joined us. We all learned about the importance of involving patients at every stage of the research process.

It wasn't just lectures! 💡 We also discussed the ethics of cancer research. The communication team (@ccsupf.bsky.social) also helped doctoral candidates produce short introductory videos for the website! 🎬 A key step towards making their research accessible to diverse audiences.

The training covered all the key content! 📚 We explored the clinical aspects of metastatic neuroblastoma, as well as breast and prostate cancers. We also looked at scientific methods such as single-cell mechanics and organ-on-chip technology.🔬

Before the kick-off, we held the first training session (23 - 24- 25 June) for our doctoral candidates at @erasmusmc.bsky.social ! 🧠 We're not just about scientific expertise; we're also focused on their professional and personal development. 🌱

🎊 The Mac4Me Doctoral Network officially kicked off two weeks ago (25-26 June)! 🎉 Our core partners gathered to set the stage for four years of research. We're excited for what's ahead!

On European Patients' Rights Day, we remember that patients deserve effective treatment and clear information. Mac4Me's research aims to personalise immunotherapies for metastatic cancers, better predict treatment outcomes and keep people informed all the way through.
Learn more at mac4me.eu

On this #WomensDay, we recognise the impact of breast cancer on women around the world. Today, we remark the dedication of female researchers who are advancing metastasis understanding and the vital role of women's perspectives in shaping more effective and inclusive cancer care and research.

Mac4Me brings together 14 partners across Europe, training 18 Doctoral Candidates to transform cancer metastasis research. Learn more about our international consortium and approach at mac4me.eu

🎉 Yesterday we launched online Mac4Me - an European doctoral network studying Macrophage Targets for Metastatic Treatment! We are investigating neuroblastoma, breast, and prostate cancers - three tumor types that share metastatic spread to brain, bone, and liver.